May is Ehlers-Danlos Syndrome (EDS) and hypermobility spectrum disorder awareness month. EDS encompasses various connective tissue disorders with distinct subtypes. Understanding these differences—such as hypermobile, classical, and vascular EDS—guides care decisions, prognosis, and family risk assessment. Genetic counseling can clarify diagnoses and help manage symptoms effectively.
Hello everyone, For many people, standing up is automatic. For others, it comes with dizziness, a racing heart, fatigue, brain
Hello everyone, November is Epilepsy Awareness Month, a time to shine a light on the millions of people worldwide living
At MKGenetix, we know that conversations about breast cancer can stir up many emotions such as fear, confusion, and sometimes
What is SIDS? Sudden Infant Death Syndrome (SIDS) is the unexpected and unexplained death of an otherwise healthy baby under
Genetic testing plays a crucial role in understanding autism spectrum disorder (ASD), offering insights into underlying genetic conditions that may impact health and development. While not every test provides conclusive results, genetic counselors assist families in navigating options, interpreting results, and empowering informed decisions for better care and family planning.
MKGenetix addresses the issues faced by individuals with rare connective tissue disorders, such as Ehlers-Danlos syndrome, often hindered by medical gaslighting. This phenomenon involves healthcare professionals dismissing symptoms as stress or anxiety, impacting patient confidence. Genetic counseling at MKGenetix offers validation, support, and advocacy, empowering patients in their healthcare journey.
Carrier screening is a genetic test that helps prospective parents understand their genetic background regarding inherited conditions. It’s recommended for everyone planning a pregnancy, as it empowers informed decisions. Genetic counseling aids in interpreting results and exploring reproductive options. MKGenetix offers personalized support for this important journey.
Sickle cell anemia is a hereditary blood disorder affecting hemoglobin, leading to severe pain and other complications. Advances in genetic counseling, treatment options like gene therapy, and strong community support are improving patient management and outcomes. Organizations provide resources for education and advocacy, fostering resilience and hope for affected individuals.
Newborn screening, a vital public health initiative, enables early detection of serious, treatable conditions in infants. Recently, the federal government disbanded the advisory committee overseeing this program, jeopardizing its future. MKGenetix emphasizes the need for public awareness and action to maintain equitable access to screenings and safeguard children’s health.
